Search Results

Showing results 11-21 of 23 for 'Immunotherapy'


  • group-of-t-cells-attack-tn
    T-cell Therapies for Cancer: From Outsider to Pharmaceutical Darling

    As Britain's Royal Pharmaceutical Society reports in its <em>Pharmaceutical Journal</em>, researchers working on T-cell therapies for cancer – such as Weizmann's Prof. Zelig Eshhar – were snubbed for years… until now. This thorough overview of the field's beginning – including in Prof. Eshhar's lab – and its future makes clear the importance of T cells.

    /news-media/in-the-news/t-cell-therapies-for-cancer-from-outsider-to-pharmaceutical-darling
  • Can-Boosting-Immunity-Make-You-Smarter-thumb
    Can Boosting Immunity Make You Smarter?

    A former PhD student of Prof. Michal Schwartz's – Prof. Jonathan Kipnis of the University of Virginia School of Medicine – has discovered that the immune system engages the brain in an intricate dialogue that may help raise IQ. As Discover reports, he first had the ""crazy idea"" in Prof. Schwartz's pioneering lab at Weizmann.

    /news-media/in-the-news/can-boosting-immunity-make-you-smarter
  • Immune_System_May_Also_Help_Brain
  • the-transformation-tn
    The Transformation

    Writing in The New Yorker, Dr. Jerome Groopman examines whether controlling cancer is a more viable option than trying to destroy it. A new treatment for the often-fatal acute myelogenous leukemia (AML) aims to do just that by forcing immature cells to grow up, rather than turn into leukemia cells – a breakthrough that builds on the work of Weizmann's Prof. Leo Sachs.

    /news-media/in-the-news/the-transformation
  • eshhar-zelig-tn
    Six Leading Scientists to Receive Prestigious Novartis Prizes for Immunology at 16th International Congress of Immunology

    Prof. Zelig Eshhar, whose basic research led to the creation of cancer-killing T-cells, is one of six scientists to receive a 2016 Novartis Prize for Immunology. Announced and granted by the healthcare and pharma company, the prestigious prizes are ""awarded every three years for breakthrough contributions to the fields of basic and clinical immunology.""

    /news-media/in-the-news/six-leading-scientists-to-receive-prestigious-novartis-prizes-for-immunology-at-16th-international-congress-of-immunology
  • neuroimmunity-michal-schwartz-tn
    Why Boosting Your Immune System Is Important for Your Brain's Health

    Good Housekeeping covers Prof. Michal Schwartz's game-changing research showing that a healthy immune system helps protect our brains. As her new book explains, she discovered that the immune system plays a previously unknown, crucial role in several diseases, and may even ""help cure Alzheimer's, depression, Parkinson's, and more.""

    /news-media/in-the-news/why-boosting-your-immune-system-is-important-for-your-brains-health
  • Emily-Whitehead-thumb
    Therapy Programs Patients’ Own Cells to Fight Cancer

    A decades-old ""audacious idea"" by Weizmann's Prof. Zelig Eshhar helped create a cancer treatment that has now led to full remissions in almost 20 adult and pediatric blood-cancer patients. Considered the future of cancer research by many, the therapy programs the patient's own immune cells to recognize and attack cancer.

    /news-media/other/therapy-programs-patients-own-cells-to-fight-cancer
  • schwartzheader438188dac497647cb66dff00005fc039
    Prof. Michal Schwartz Will Change Your Mind

    Prof. Michal Schwartz's new book shares her breakthrough discovery that the immune system and brain communicate, and how this could lead to slowing – even reversing – brain aging and neurodegeneration.

    /news-media/other/prof-michal-schwartz-will-change-your-mind
  • What is Immunotherapy?
  • Untitled-2-1[1]-Eshhar-1.jpg
    Breakthrough Israeli Cancer Professor on Prowl to Ease Other Ills

    Prof. Zelig Eshhar’s phones haven’t stopped ringing since the news broke two days ago that Israeli-founded Kite Pharma would be bought by US pharma company Gilead Sciences Inc. for a whopping $12 billion. Eshhar, a researcher at Israel’s Weizmann Institute of Science, developed the technology which is at the heart of Monday’s acquisition. He is also on Kite’s scientific advisory board, and was one of the first people to get a call from Kite CEO and founder, Israeli-American oncologist Arie Belldegrun, after the deal was signed.

    /news-media/in-the-news/breakthrough-israeli-cancer-professor-on-prowl-to-ease-other-ills